rdf:type |
|
lifeskim:mentions |
|
pubmed:issue |
3
|
pubmed:dateCreated |
2009-3-5
|
pubmed:abstractText |
To investigate the effects of allisartan, a new angiotensin II type 1 (AT(1)) receptor antagonist, on blood pressure (BP) and end-organ damage (EOD) in hypertensive rats and dogs.
|
pubmed:language |
eng
|
pubmed:journal |
|
pubmed:citationSubset |
IM
|
pubmed:chemical |
|
pubmed:status |
MEDLINE
|
pubmed:month |
Mar
|
pubmed:issn |
1745-7254
|
pubmed:author |
|
pubmed:issnType |
Electronic
|
pubmed:volume |
30
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
307-13
|
pubmed:meshHeading |
pubmed-meshheading:19262554-Angiotensin II Type 1 Receptor Blockers,
pubmed-meshheading:19262554-Animals,
pubmed-meshheading:19262554-Blood Pressure,
pubmed-meshheading:19262554-Dogs,
pubmed-meshheading:19262554-Female,
pubmed-meshheading:19262554-Heart Rate,
pubmed-meshheading:19262554-Humans,
pubmed-meshheading:19262554-Hypertension, Renovascular,
pubmed-meshheading:19262554-Kidney,
pubmed-meshheading:19262554-Losartan,
pubmed-meshheading:19262554-Male,
pubmed-meshheading:19262554-Mice,
pubmed-meshheading:19262554-Rats,
pubmed-meshheading:19262554-Rats, Inbred SHR,
pubmed-meshheading:19262554-Rats, Sprague-Dawley
|
pubmed:year |
2009
|
pubmed:articleTitle |
Effects of allisartan, a new AT(1) receptor blocker, on blood pressure and end-organ damage in hypertensive animals.
|
pubmed:affiliation |
Department of Pharmacology, Second Military Medical University, Shanghai, China.
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|